Canada’s rapid infectious disease tests developer bioLytical Laboratories has unveiled its INSTI HIV Self Test for Kenya’s Pharmaceutical Association members.

The introduction of the self-test is a result of Clinton Health Access Initiative’s (CHAI) effort to offer low-cost HIV self-tests into pharmacies in Kenya.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The INSTI HIV Self Test is a blood-based self-test and is intended to be used as a screening tool to identify individuals who are suspected to be infected with HIV.

The assay detects HIV antibodies by examining a single drop of blood and provides instant results. INSTI is easy to use and provides almost accurate results.

The INSTI HIV Self Test is an over-the-counter (OTC) version of the bioLytical’s INSTI HIV-1 / HIV-2 Antibody Test, which is a rapid, flow-through in vitro qualitative immunoassay for the detection of antibodies to HIV-1 and HIV-2 in human fingerstick whole blood.

"The assay detects HIV antibodies by examining a single drop of blood and provides instant results."

bioLytical Laboratories chief technical officer Rick Galli said: ““Kenya is leading the way in bringing HIV self-testing into sub-Saharan Africa through the private sector.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“bioLytical is excited to lead in this ground-breaking initiative that will demonstrate how a low cost, accessible HIV self-testing programme can be effective and empowering for individuals to take control of their health”.

The introduction of the test will open access to affordable HIV testing for Kenyans across the country, through local pharmacies.

Image: HIV self-testing instructions. Photo: courtesy of bioLytical Laboratories.